World Congress on Osteoporosis
Monday, May 31st, 2010Datamonitor attended this year’s International Osteoporosis Foundation World Congress on Osteoporosis and 10th European Congress on Clinical and Economical Aspects of Osteoporosis and Osteoarthritis, the most important meeting on the osteoporosis calendar. A number of major pharmaceutical firms had a presence at the meeting, indicating the significance of this market.
Pfizer: remains a small presence in the osteoporosis market
The presence of Pfizer at the congress suggests that the company intends to launch Conbriza (bazedoxifene) in the European market after it was approved in 2009. It is Datamonitor’s understanding that the company …